Maiden (MHLD) Q4 2024 earnings summary

Executive summary

• Entered into a combination agreement with Kestrel Group to form a new specialty program group and agreed to sell Swedish subsidiaries, targeting completion in Q2 2025.

• Strategic transactions support a pivot to a fee-based insurance platform and balance sheet stabilization.

• Comprehensive reserve review and significant charges in Q4 2024 aimed at increasing confidence in the balance sheet.

Financial highlights

• Book value per common share fell 81.5% to $0.46; adjusted book value per share down 52.4% to $1.52 at year-end 2024.

• Net loss attributable to common shareholders was $158.0M ($1.59/share) in Q4 2024 and $201.0M ($2.01/share) for the year, compared to $20.8M and $38.6M losses in 2023.

• Adjusted non-GAAP operating loss was $151.9M ($1.53/share) in Q4 2024 and $173.9M ($1.74/share) for the year.

• Underwriting loss of $161.3M in Q4 2024 (vs. $21.1M in Q4 2023), driven by $129.4M adverse prior year loss development.

• Investment results decreased to $4.1M in Q4 2024 from $14.6M in Q4 2023, reflecting alternative investment sales and lower income from restricted cash.

Outlook and guidance

• Management expects the Kestrel combination and IIS divestiture to support a strategic pivot and enhance balance sheet stability.

• Amortization of deferred gain under the LPT/ADC Agreement is expected to increase in 2025, improving future GAAP income.

• No new commitments to alternative investments are planned; further reductions in the portfolio are being evaluated.